Paul W. Schaffer is Director at Sun BioPharma, Inc. (SNBP). They have made 1 open-market trade across 1 company since 2016, most recently 2021-05-25.
CIK 0001652797
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $125K since 2016, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SNBP | BUY | 2020-09-04 | 2020-09-09 | $2.51 | $125K | +12.5% | +19.1% | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.